Management of Muscle Injury and Myofascial Pain Syndromes

Gatterman, Meridel I.; McDowell, Bonnie L.

doi:10.1016/b978-0-323-04583-4.00006-0

Cited by 5 publications

(3 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…13 Ischemic compression is applied with enough manual pressure to produce skin blanching in the treatment area and can result in a reduction in pain score. 14 Laser therapy studies have shown conflicting results in the treatment of myofascial trigger points, which could be attributed to the range of parameters used in the treatment and limited depth of penetration. 15 Low-intensity ultrasound produces mechanobiological effects stimulating cellular and tissue mechanisms treating multiple conditions, including myofascial trigger points, [16][17][18][19] back pain, 20,21 tendinopathy, 22,23 and joint arthritis pain.…”

Section: Introductionmentioning

confidence: 99%

<p>Low-Intensity Continuous Ultrasound for the Symptomatic Treatment of Upper Shoulder and Neck Pain: A Randomized, Double-Blind Placebo-Controlled Clinical Trial</p>

Petterson¹,

Plancher

Klyve

et al. 2020

JPR

View full text Add to dashboard Cite

Low-intensity continuous ultrasound (LICUS) is an emerging high-dosimetry ultrasound-based therapy for accelerated tissue healing and the treatment of myofascial pain. In this study, LICUS treatment is clinically evaluated for chronic upper neck and shoulder pain in a randomized, multi-site, double-blind, placebo-controlled study. Patients and Methods: CONSORT guidelines were followed in conducting and reporting the clinical trial. Thirty-three participants with upper trapezius myofascial pain were randomized for treatment with active (n=25) or placebo (n=8) devices. Investigators and subjects were blinded to treatment groups. Participants self-reported pain daily, rating from 0-10 on the numeric rating scale. If pain rating was more significant than or equal to 3, the LICUS (3MHz, 0.132W/cm 2 , 1.3W, 4 hours) was self-applied for total energy dosimetry of 18,720 Joules per treatment. During the 4-week study, daily pain rating was recorded. If LICUS treatment was delivered, pain before, during, and after treatment were recorded as well as the global rate of change (GROC). Independent t-tests were used to assess change from baseline and differences between treatment groups. ClinicalTrials.gov: NCT02135094. Results: There was a 100% completion rate for participants enrolled in the study and no significant differences between the groups regarding demographic variables or baseline outcome measures. Participants treated with active therapy observed a significant mean pain reduction from baseline of 2.61 points for active (p<0.001), compared to 1.58 points decrease from baseline for placebo (p=0.087), resulting in a 1.03 points significant decrease in the active group over placebo (p=0.003). The total GROC was significantly higher in the active group at 2.84 points compared to the placebo group at 0.46 points (p<0.001). Conclusion: Low-intensity continuous ultrasound treatment significantly reduced pain in patients with upper trapezius myofascial pain of the neck and shoulder. LICUS treatment showed a clinically meaningful improvement in the GROC scores for patients. The results from this clinical trial indicate that the LICUS treatment of 18,720 Joules can effectively be used to treat clinical pain related to upper trapezius myofascial pain. Further research could investigate varying dosimetry to improve efficacy and/or reduce the dose.

show abstract

Section: Introductionmentioning

confidence: 99%

<p>Low-Intensity Continuous Ultrasound for the Symptomatic Treatment of Upper Shoulder and Neck Pain: A Randomized, Double-Blind Placebo-Controlled Clinical Trial</p>

Petterson¹,

Plancher

Klyve

et al. 2020

JPR

View full text Add to dashboard Cite

show abstract

“…The temporalis is ideally approached perpendicularly as high as possible due to the fan-shaped anatomy of the muscle. For temporalis, the starting dose is 10-20 units for Ona-BoNT and Inco-BoNT and 60-80 units for Abo-BoNT [20][21][22][23].…”

Section: Jaw-closing Dystoniamentioning

confidence: 99%

Chemodenervation for Oromandibular Dystonia Utilizing Botulinum Toxins

Ameer¹,

Bhatti²

2021

Cureus

View full text Add to dashboard Cite

Oromandibular dystonia (OMD) is a chronic focal dystonia that involves the mouth, jaw, and tongue. It may cause repetitive or sustained dystonic movements, which can be very disabling for patients. It is usually a life-long disorder with numerous treatment options that are, most often, partially curative. In our experience, the best modality to treat OMD is botulinum toxin (BoNT) injections, which not only provide long-term relief but also have fewer adverse effects compared to other medications. Although multiple small-and large-scale studies support this fact, there is still a need for evidence from large randomized clinical trials. Jaw-closing dystonia responds very well to BoNT injections compared to other subtypes of OMD. This review discusses in detail the evidence, injection technique, and typical starting doses for botulinum injection.

show abstract

“…The teres minor muscle lies just inferior to the infraspinatus muscle. It arises from the dorsal surface of the scapula and inserts into the most inferior greater tubercle facet (Gatterman & McDowell, 2012;Terry & Chopp, 2000). Its functions are similar to that of the infraspinatus muscle.…”

mentioning

confidence: 99%

Using biomechanical data to explore the utility of exoskeleton intervention for work-related musculoskeletal disorders in the surgeons

Tetteh

View full text Add to dashboard Cite

show abstract

Management of Muscle Injury and Myofascial Pain Syndromes

Cited by 5 publications

References 42 publications

<p>Low-Intensity Continuous Ultrasound for the Symptomatic Treatment of Upper Shoulder and Neck Pain: A Randomized, Double-Blind Placebo-Controlled Clinical Trial</p>

<p>Low-Intensity Continuous Ultrasound for the Symptomatic Treatment of Upper Shoulder and Neck Pain: A Randomized, Double-Blind Placebo-Controlled Clinical Trial</p>

Chemodenervation for Oromandibular Dystonia Utilizing Botulinum Toxins

Using biomechanical data to explore the utility of exoskeleton intervention for work-related musculoskeletal disorders in the surgeons

Contact Info

Product

Resources

About